Bayesian Capital Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$35.1M |
| 2 |
ExxonMobil
XOM
|
+$7.27M |
| 3 |
Occidental Petroleum
OXY
|
+$6.26M |
| 4 |
Tyson Foods
TSN
|
+$6.08M |
| 5 |
Walt Disney
DIS
|
+$5.78M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
FedEx
FDX
|
+$8.9M |
| 2 |
Comcast
CMCSA
|
+$7.55M |
| 3 |
Advanced Micro Devices
AMD
|
+$6.75M |
| 4 |
Oracle
ORCL
|
+$6.58M |
| 5 |
AT&T
T
|
+$6.04M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.25% |
| 2 | Consumer Discretionary | 11.52% |
| 3 | Healthcare | 10.6% |
| 4 | Industrials | 9.71% |
| 5 | Financials | 8.34% |
Similar funds
Bayesian Capital Management's Q1 2022 Portfolio in Review
As of Q1 2022, Bayesian Capital Management held 972 positions worth $670M, up 112% from $316M the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Bayesian Capital Management deployed $355M of net new capital in Q1 2022, opening 611 new positions and adding to 91 existing holdings. Its largest new stake was State Street SPDR S&P 500 ETF Trust: 78,800 shares worth $35.6M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 28% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was Oracle, an estimated $6.58M trimmed.
- Bayesian Capital Management's largest Q1 2022 buy was State Street SPDR S&P 500 ETF Trust: 78,800 shares worth $35.6M.
- Bayesian Capital Management added most to Coca-Cola in Q1 2022, an estimated $4.81M increase.
- Bayesian Capital Management's biggest Q1 2022 reduction was Oracle, cutting an estimated $6.58M.
- Bayesian Capital Management fully exited FedEx in Q1 2022, selling an estimated $8.9M.
- Bayesian Capital Management's ten largest holdings make up 13% of its $670M portfolio in Q1 2022.
- Bayesian Capital Management opened 611 new positions and closed 218 in Q1 2022.
- Bayesian Capital Management's portfolio value rose 112% quarter-over-quarter to $670M.
Based on Bayesian Capital Management's 13F filing for Q1 2022, filed 16 May 2022.